Psychosocial Counseling in Afghanistan

Stress Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01155687
• Other study ID #: EuropeAid/127054/C/SER/MULTI
• Status: Completed
• Phase: N/A
• First received: June 30, 2010
• Last updated: August 8, 2011
• Start date: September 2009
• Est. completion date: July 2010

Study information

• Verified date: June 2010
• Source: University of Konstanz
• Contact: n/a
• Is FDA regulated: No
• Health authority: Afghanistan: Ministry of Public Health
• Study type: Observational

Clinical Trial Summary

The assessment intends to investigate the efficacy of psychosocial counseling for the treatment of help seeking individuals with psychosocial problems in Mazar-e-Sharif, Afghanistan. Treatment was administered by local counselors who had received specific education and training

Description:

Psychosocial stress due to conflict and war causes major mental health problems in many resource-poor countries, especially those coping with ongoing war-like conditions. There is a lack of intervention research in these population. The purpose of this assessment was to examine whether the type of psychosocial counseling developed by our group is effective in reducing symptoms of depression and anxiety and significantly increasing the quality of life of help-seeking Afghans.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 61
• Est. completion date: July 2010
• Est. primary completion date: July 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 14 Years and older

Eligibility

Inclusion Criteria:

• Diagnosis of mental health problems by a local medical doctor

Exclusion Criteria:

• Schizophrenia

• Mental retardation

Study Design

Observational Model: Case Control

Related Conditions & MeSH terms

• Mental Health
• Stress

Locations

Country	Name	City	State
Afghanistan	Counseling Center Mazar-e-Sharif	Mazar-e-Sharif	Balkh

Sponsors (2)

Lead Sponsor	Collaborator
University of Konstanz	European Union

Country where clinical trial is conducted

Afghanistan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	HSCL 25	Symptoms of Depression and Anxiety measured with the HSCL 25	Symptoms were assessed at baseline	No
Primary	HSCL 25	Symptoms of Depression and Anxiety measured with the HSCL 25	3-month follow-up	No
Primary	HSCL 25	Symptoms of Depression and Anxiety measured with the HSCL 25	Assessment at 12-month-follow-up	No
Secondary	M.I.N.I. (Mini-International Neuropsychiatric Interview)	To assess, if the patients have a current Major Depression, the depression section from the "Mini-International Neuropsychiatric Interview" (Sheehan, & Janavs, 1998) was included	Symptoms were assessed at baseline	No
Secondary	Psychosocial stressors and coping mechanism	Psychosocial stressors and coping mechanism of the participants were investigated in expert interviews	Symptoms were assessed at baseline	No
Secondary	Screening for Depression	A culturally grounded assessment measure developed in close collaboration with a team of Afghan experts explored current depressive symptoms	Symptoms were assessed at baseline	No
Secondary	M.I.N.I. (Mini-International Neuropsychiatric Interview)	To assess, if the patients have a current Major Depression, the depression section from the "Mini-International Neuropsychiatric Interview" (Sheehan, & Janavs, 1998) was included	Assessment at 3-month-follow-up	No
Secondary	M.I.N.I (Mini-International Neuropsychiatric Interview)	To assess, if the patients have a current Major Depression, the depression section from the "Mini-International Neuropsychiatric Interview" (Sheehan, & Janavs, 1998) was included	Assessment at 12-month-follow-up	No
Secondary	Psychosocial stressors and coping mechanism	Psychosocial stressors and coping mechanism of the participants were investigated in expert interviews	Assessment at 3-month-follow-up	No
Secondary	Psychosocial stressors and coping mechanism	Psychosocial stressors and coping mechanism of the participants were investigated in expert interviews	Assessment at 12-month-follow-up	No
Secondary	Screening for Depression	A culturally grounded assessment measure developed in close collaboration with a team of Afghan experts explored current depressive symptoms	Assessment at 3-month-follow-up	No
Secondary	Screening for Depression	A culturally grounded assessment measure developed in close collaboration with a team of Afghan experts explored current depressive symptoms	Assessment at 12-month-follow-up	No